期刊文献+

恶性疟原虫保护性抗原复合基因—痘苗病毒重组活疫苗株家兔免疫血清及IgG对恶性疟原虫的体外抑制试验 被引量:4

INHIBITION OF RABBIT SERA AND IgG TO PLASMODIUM FALCIPARUM INDUCED WITH A VACCINIA VECTORED MULTI EPITOPE LIVE VACCINE CANDIDATE
下载PDF
导出
摘要 用恶性疟原虫痘苗病毒重组活疫苗候选株的家兔免疫血清及纯化的IgG 进行了恶性疟原虫的体外培养抑制试验,并与该目的基因的原核表达蛋白及全虫抗原进行了比较。结果在疟原虫的第一个生长周期内,重组痘苗病毒组的免疫血清抑虫作用最强(P< 0.05),其次为全虫抗原及原核蛋白组;IgG 则在第一及第二个生长周期均以原核表达蛋白组抑虫作用最强( P< 0.05) ,其次为重组痘苗病毒及全虫抗原组。说明重组痘苗病毒免疫血清及IgG具有一定的体外抑制恶性疟原虫增殖作用,值得进一步深入研究。 Rabbit sera and IgG induced with a vaccina virus vectored multi epitope live vaccine candidate were tested for inhibition to the multiplication of Plasmodium falciparum(P.f.) in vitro. The prokaryotic expression protein of this multi epitope gene and whole parasite antigen were also compared. Results showed that the group of anti recombinant vaccinia virus sera had a strongest capability of inhibiting P.f. in 24 hours(first cycle), and the groups of prokaryotic expression protein and whole parasite antigen next. In IgG experiments, the group of prokaryotic expression protein showed a strongest inhibiting ability, the next were the groups of recombinant vaccinia virus and whole parasite antigen in 24 and 72 hours(first and second cycle). These indicated that the rabbit anti recombinant vaccinia virus live vaccine candidate had some inhibition ability to the multiplication of P.f. in vitro .
出处 《中国寄生虫病防治杂志》 CSCD 1999年第4期250-252,共3页 Chinese Journal of Parasitic Disease Control
基金 世界卫生组织热带病研究培训特别规划处资助
关键词 恶性 疟原虫 痘苗病毒 疫苗 体外抑制 IGG Plasmodium falciparum gene vaccinia virus vaccine in vitro inhibition
  • 相关文献

参考文献1

共引文献5

同被引文献33

  • 1李全贞,李英杰,谢毅,任大明.恶性疟原虫基因工程疫苗的研究——Ⅰ.恶性疟原虫保护性抗原复合基因的合成与克隆[J].第一军医大学学报,1993,13(3):199-207. 被引量:8
  • 2李全贞,毕惠祥,李英杰,谢毅,任大明,徐秉锟.抗恶性疟重组复合抗原的免疫血清对恶性疟原虫体外生长的抑制作用[J].中国寄生虫学与寄生虫病杂志,1995,13(3):209-213. 被引量:9
  • 3Chow YH, Huang Wl, Chi WK, et al. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressiong hepatitis B surface antigen and interleukin-2[J].J Virol, 1997,71(1):169-178.
  • 4Weidmann E, Brieger J, Jahn B, et al. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia[J].Ann Hematol,1995,70(3):153-158.
  • 5Good MF, Doolan DL. Immune effector mechanisms in malaria[J].Curr Opin Immunol,1999,11(4):412-419.
  • 6Good MF. A malaria vaccine strategy based on the induction of cellular immunity[J].Immunol Today,1992,13(4):126-30.
  • 7Wang R,Doolan DL,Le TP,et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine[J]. Science, 1998, 282(5388):476-480.
  • 8Mohan k, Moulin P, Stevenson NM. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS intection[J].J Immunol,1997, 159:4990-4998.
  • 9Haddad D,Liljeqvist S,Stahl S,et al. Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice[J]. FEMS Immunol Med Microbiol,1997, 18(3):193-202.
  • 10Green SJ,Scheller LF,Marletta MA,et al. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens[J]. Immunol Lett,1994,43(1-2):87-94.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部